相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: A comparative approach with genotype 1 chronic hepatitis C
E. Tsochatzis et al.
DIGESTIVE AND LIVER DISEASE (2007)
Serum adiponectin in chronic hepatitis C and B
D. Siagris et al.
JOURNAL OF VIRAL HEPATITIS (2007)
Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B
Chee-Kin Hui et al.
JOURNAL OF HEPATOLOGY (2007)
An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study
Spilios Manolakopoulos et al.
BMC GASTROENTEROLOGY (2007)
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C
O. Lo Iacono et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors
Emmanuel Tsochatzis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Resistin as an intrahlepatic cytokine -: Overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells
Cristiana Bertolani et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The evolving role of leptin and adiponectin in chronic liver diseases
Emmanuel Tsochatzis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Metabolic and adipokine profile of chinese patients with nonalcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases
E Yagmur et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Resistin
PG McTernan et al.
CURRENT OPINION IN LIPIDOLOGY (2006)
High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection
AYH Wang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Adiponectin and its receptors in patients with chronic hepatitis C
JR Jonsson et al.
JOURNAL OF HEPATOLOGY (2005)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C
L Fartoux et al.
GUT (2005)
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
E Bugianesi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Serum adiponectin concentration in patients with hepatitis C virus
S Sato et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients
A Muzzi et al.
JOURNAL OF HEPATOLOGY (2005)
Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics
UJF Tietge et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease
P Angulo et al.
JOURNAL OF HEPATOLOGY (2004)
The severity of liver fibrosis is associated with high leptin levels in chronic Hepatitis C
T Piche et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?
S Chitturi et al.
HEPATOLOGY (2002)
Plasma leptin and TNF-α levels in chronic hepatitis C patients and their relationship to hepatic fibrosis
J Crespo et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
分享论文
